Component information
No US or EU label exists for this exact combination, so information is shown for each component.
- bupivacaine w no separate page
Use: Dextrose (50%) Injection is indicated for the treatment of insulin-induced hypoglycemia (e.g., hyperinsulinemia, insulin shock) in adults and pediatric patients 2 years of age and older. US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Solution for injection: 5 mg/mL
Registered products in the Philippines
2 products registered with the Food and Drug Administration (FDA) Philippines list Bupivacaine w + Dextrose as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Bupivaxine-DBupivacaine (as hydrochloride) w/ Dextrose | 5 mg /mL Solution for Injection (Intrathecal)USP Type I Flint Ampoule x 4 mL (Box of 10 ampoules in plastic tray) | Rx | Kilitch Drugs (India) Ltd.India | Delex Pharma International, Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-13481-02 | Feb 23, 2028 | |
ZarcaineBupivacaine (as hydrochloride) w/ Dextrose | 5 mg/mL Solution for Injection (Intrathecal)USP Type I Flint Ampoule x 4 mL (Box of 10 ampoules in plastic tray) | Rx | Kilitch Drugs (India) Ltd.India | Rifemedica CorporationImporter: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-13481-01 | Feb 23, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .